2021 MIPS Measure #476: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

Measure TypeHigh Priority Measure?Collection Type(s)
Patient Reported OutcomeyeseCQM


Measure Description

Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points.


CMS-Family-Medicine-2021, CMS-Geriatrics-2021, CMS-Infectious-Disease-2021, CMS-Internal-Medicine-2021, CMS-Obstetrics-Gynecology-2021, CMS-Preventive-Medicine-2021, CMS-Urology-2021, Internal Medicine, Obstetrics/Gynecology, Preventive Medicine, Quality-2021